Want to see TSE:EXE full AI Analyst Report?
EXE Stock Chart & Stats
C$29.10
-C$0.01(-0.10%)
At close: 4:00 PM EST
C$29.10
-C$0.01(-0.10%)
Day’s Range― - ―
52-Week RangeC$12.12 - C$37.59
Previous CloseN/A
Volume30.42K
Average Volume (3M)175.59K
Market Cap
C$3.52B
Enterprise ValueC$3.13B
Total Cash (Recent Filing)C$322.27M
Total Debt (Recent Filing)C$324.56M
Price to Earnings (P/E)26.8
Beta0.50
Next Earnings
Aug 06, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend Yield2.28%
Share Statistics
EPS (TTM)1.38
Shares Outstanding95,046,400
10 Day Avg. Volume108,359
30 Day Avg. Volume175,588
Financial Highlights & Ratios
PEG Ratio1.15
Price to Book (P/B)4.88
Price to Sales (P/S)1.10
P/FCF Ratio28.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$38.42Price Target Upside32.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)1.48
Revenue Forecast (FY)C$2.25B
Bulls Say, Bears Say
Bulls Say
Improving ProfitabilityEBITDA and net margins have meaningfully rebounded versus 2023, reflecting better operating control and pricing mix. Sustained margin recovery increases internal cash generation capacity, improves resilience to reimbursement pressure and supports reinvestment or servicing of obligations over the next several months.
Stronger Balance SheetMaterial deleveraging and a larger equity base materially reduce credit and refinancing risk. A lower debt-to-equity ratio improves financial flexibility to fund maintenance capex, pursue accretive contracts or withstand rate volatility, which supports the company's strategic options over a multi-month horizon.
Diversified Senior-Care Revenue BaseHaving LTC operations, home health services and ancillary support lines creates multiple, largely publicly funded revenue streams. This structural diversification reduces single-market dependency and makes revenues more predictable across contract renewals and occupancy cycles over the medium term.
Bears Say
Weak Cash ConversionPersistent weak cash conversion versus accounting earnings and a ~23% TTM decline limit the firm's ability to sustainably fund dividends, unexpected capex or absorb shocks. Volatile FCF history raises the risk that earnings gains may not reliably translate into spendable cash in coming quarters.
Modest Net MarginsNet margins in the mid-single-digits offer limited buffer against structural cost pressures common in senior care, such as rising wages or changes in provincial reimbursement. Even modest adverse moves in occupancy or funding could materially compress profitability and cash flow.
Meaningful Remaining DebtAlthough leverage improved, ~C$325M of debt still implies ongoing interest and maturity obligations. In a higher-rate environment or if cash conversion falters, this remaining leverage could constrain capital allocation, limit strategic investments and elevate refinancing risk over the medium term.
Extendicare News
EXE FAQ
What was Extendicare’s price range in the past 12 months?
Extendicare lowest stock price was C$12.12 and its highest was C$37.59 in the past 12 months.
What is Extendicare’s market cap?
Extendicare’s market cap is C$3.52B.
When is Extendicare’s upcoming earnings report date?
Extendicare’s upcoming earnings report date is Aug 06, 2026 which is in 23 days.
How were Extendicare’s earnings last quarter?
Extendicare released its earnings results on May 07, 2026. The company reported C$0.422 earnings per share for the quarter, beating the consensus estimate of C$0.21 by C$0.212.
Is Extendicare overvalued?
According to Wall Street analysts Extendicare’s price is currently Undervalued.
Does Extendicare pay dividends?
Extendicare pays a Monthly dividend of C$0.044 which represents an annual dividend yield of 2.28%. See more information on Extendicare dividends here
What is Extendicare’s EPS estimate?
Extendicare’s EPS estimate is 0.4.
How many shares outstanding does Extendicare have?
Extendicare has 95,046,400 shares outstanding.
What happened to Extendicare’s price movement after its last earnings report?
Extendicare reported an EPS of C$0.422 in its last earnings report, beating expectations of C$0.21. Following the earnings report the stock price went up 10.727%.
Which hedge fund is a major shareholder of Extendicare?
Currently, no hedge funds are holding shares in TSE:EXE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Extendicare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$38.42 (32.02% Upside)
C$38.42 (32.02% Upside)
Insider Transactions
Sold Shares
Worth C$65.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 4.1%
Last 30 Days ▲ 4.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
67.69%
12-Months-Change
Fundamentals
Return on Equity
45.35%
Trailing 12-Months
Asset Growth
50.12%
Trailing 12-Months
Company Description
Extendicare
Extendicare Inc. operates across Canada, delivering a wide array of vital care and support services specifically designed for the senior population through its various subsidiaries. The company's diverse service portfolio includes long-term care facilities, a range of retirement living options, and comprehensive home-based health services. These home health offerings span professional nursing care, various rehabilitative therapies (including occupational, physical, and speech therapy), and assistance with everyday activities. Additionally, Extendicare offers contract and consulting expertise to external entities. The organization oversees an extensive network consisting of 119 long-term care residences and retirement communities, alongside its dedicated home health care operations. These services are provided under prominent brand names such as Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network. Founded in 1968, Extendicare Inc. is headquartered in Markham, Canada.
EXE Stock 12 Month Forecast
Average Price Target
C$38.42
▲(32.02% Upside)
Technical Analysis
Options Prices
Currently, No data available
---